Press "Enter" to skip to content

AAS Funding for Covid-19 Research & Development Goals for Africa

Application Deadline: June 30th 2020

The COVID-19 pandemic has brought unprecedented challenges for Africa, with every country potentially at risk for unmitigated spread of SARS-CoV2. Like most health systems in the world, there is a risk for current levels of care to be overwhelmed by sheer volume of patients requiring intensive care and ventilatory support. In addition, health care workers are at risk of acquiring SARS-CoV2 and given limited infection control practices in many settings, there is also risk of nosocomial transmission of SARS-CoV2 among patients.

The African Academy of Sciences (AAS) is keen to play a central role in building African Research and Development (R&D) capacity to fight COVID-19 by managing day-to-day running of the proposed fund for COVID-19 R&D priorities in Africa.  A recent survey of African scientists conducted by the AAS developed initially from an AAS ‘’All Hands’’ webinar on COVID-19 held on 26th March 2020 and conducted from the 4th to 8th of April 2020 established a priority list of Research and Development questions for the COVID-19 outbreak in Africa. The results of the survey can be found here.

This call supported by Sida (Sweden), Wellcome Trust, and Bill and Melinda Gates Foundation is therefore a call to action for African scientists to attend to the research and development needs of the COVID-19 outbreak for the continent as identified by African scientists. There is need to provide robust scientific evidence to the country emergency response teams. The priorities listed are widely applicable across the continent yet require local context and expertise in order to address in a timely and effective manner the issues arising even as the outbreak evolves.


  • Institution
  • Is a legal entity;
  • Is based in Africa.


  • Projects that do not primarily respond to the research and development goals of the COVID-19 public health outbreak response;
  • Projects focussing on implementation or delivery services for the COVID-19 outbreak control;
  • Projects solely focused on network building, capacity building and infrastructure projects without a working hypothesis;
  • Complex and high-risk projects that cannot be undertaken within the 24 months available;
  • Projects with minimal contribution towards the R&D priorities of the COVID-19 outbreak.

Award Details

  • Award period

Funding may be requested for an implementation period of up to two years (24 months).

  • Award amount

The maximum amount allowable for a single grant is US$200,000 to be held for two (2) years.

Costs categories are:

  • Materials and consumables
  • Capital Costs/Equipment
  • Research Training Costs
  • Other Research Costs
  • Office Administrative Costs
  • Salaries
  • Cost challenges shall be made at the triage stage.

For more information visit.


Be First to Comment

Leave a Reply

Mission News Theme by Compete Themes.